615 related articles for article (PubMed ID: 29214453)
1. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
[TBL] [Abstract][Full Text] [Related]
2. Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis.
Kamarajah SK; Bundred JR; Boyle C; Oo J; Pandanaboyana S; Loveday B
ANZ J Surg; 2020 Nov; 90(11):2201-2210. PubMed ID: 32418344
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
[TBL] [Abstract][Full Text] [Related]
4. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy.
McMillan MT; Christein JD; Callery MP; Behrman SW; Drebin JA; Hollis RH; Kent TS; Miller BC; Sprys MH; Watkins AA; Strasberg SM; Vollmer CM
Surgery; 2016 Apr; 159(4):1013-22. PubMed ID: 26670325
[TBL] [Abstract][Full Text] [Related]
5. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
[TBL] [Abstract][Full Text] [Related]
6. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
[TBL] [Abstract][Full Text] [Related]
7. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy.
Hank T; Sandini M; Ferrone CR; Rodrigues C; Weniger M; Qadan M; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
JAMA Surg; 2019 Oct; 154(10):943-951. PubMed ID: 31411659
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
9. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer.
Donovan EC; Prakash LR; Chiang YJ; Bruno ML; Maxwell JE; Ikoma N; Tzeng CD; Katz MHG; Lee JE; Kim MP
J Gastrointest Surg; 2023 Feb; 27(2):319-327. PubMed ID: 36443557
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
[TBL] [Abstract][Full Text] [Related]
12. Postoperative pancreatic fistula: We need to redefine grades B and C.
Hackert T; Hinz U; Pausch T; Fesenbeck I; Strobel O; Schneider L; Fritz S; Büchler MW
Surgery; 2016 Mar; 159(3):872-7. PubMed ID: 26603847
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma.
Rykina-Tameeva N; Nahm CB; Mehta S; Gill AJ; Samra JS; Mittal A
HPB (Oxford); 2020 Nov; 22(11):1631-1636. PubMed ID: 32247587
[TBL] [Abstract][Full Text] [Related]
14. Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
Dominguez OH; Grigorian A; Wolf RF; Imagawa DK; Nahmias JT; Jutric Z
Updates Surg; 2023 Apr; 75(3):523-530. PubMed ID: 36309940
[TBL] [Abstract][Full Text] [Related]
15. Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry.
Sternby H; Andersson B
Scand J Gastroenterol; 2022 Nov; 57(11):1361-1366. PubMed ID: 35635264
[TBL] [Abstract][Full Text] [Related]
16. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis.
Uchida Y; Masui T; Nagai K; Anazawa T; Yoshimura M; Uza N; Takaori K; Mizowaki T; Uemoto S
Surg Oncol; 2020 Dec; 35():527-532. PubMed ID: 33160278
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.
Mostafa A; Habeeb TA; Neri V; Elshahidy TM; A Fiad A
Ann Ital Chir; 2023; 94():435-442. PubMed ID: 38051507
[TBL] [Abstract][Full Text] [Related]
18. Role of TachoSil® in distal pancreatectomy: a single center experience.
Silvestri S; Franchello A; Gonella F; Deiro G; Campra D; Cassine D; Fiore A; Ostuni E; Garino M; Resegotti A; Farina EC; Fronda GR
Minerva Chir; 2015 Jun; 70(3):175-80. PubMed ID: 25960031
[TBL] [Abstract][Full Text] [Related]
19. Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy.
Wijetunga AR; Chua TC; Nahm CB; Pavlakis N; Clarke S; Chan DL; Diakos C; Maloney S; Ashrafi-Zadeh A; Kneebone A; Hruby G; Jamieson NB; Gill A; Mittal A; Samra JS
Eur J Surg Oncol; 2021 Oct; 47(10):2543-2550. PubMed ID: 33952409
[TBL] [Abstract][Full Text] [Related]
20. International Study Group of Pancreatic Surgery Definitions for Postpancreatectomy Complications: Applicability at a High-Volume Center.
Dusch N; Lietzmann A; Barthels F; Niedergethmann M; Rückert F; Wilhelm TJ
Scand J Surg; 2017 Sep; 106(3):216-223. PubMed ID: 28376656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]